Intas Pharma unveils antifungal drug SB-100mg Itraconazole

Published On 2021-10-21 11:10 GMT | Update On 2021-11-11 10:02 GMT

In a progressive breakthrough in the Antifungal Therapy domain, Intas Pharmaceuticals has launched the world's first Super Bioavailable Itraconazole-SB 100mg under the Brand Name - Itaspor-SB Forte/Subawin. It has been recently approved by Indian Regulatory Authorities.

Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage, antacids consumption etc. and overall cost of treatment.

For more details, check out the full story on the link below:

First: Intas Pharma Launches Antifungal Drug SB-100mg Itraconazole

Full View

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Intas Pharma unveils antifungal drug SB-100mg Itraconazole

Similar News